The specific aims of this study are: 1. To develop a breathing training protocol specifically designed to improve HRV and psychosocial functioning for postmenopausal women with depressive symptoms, 2. To examine the immediate effects of an 8-week breathing training program on HRV and psychosocial end points in postmenopausal women with depressive symptoms, 3. To examine the intermediate-term effects of an 8-week breathing training program on HRV and psychosocial end points in postmenopausal women with depressive symptoms, and 4. To determine whether the change in depressive symptoms with breathing training in postmenopausal women is associated with the change in HRV.
Postmenopausal women without hormone replacement therapy are associated with higher risk of cardiac morbidity and mortality. They are likely to experience depressive symptoms after menopause, and the comorbidity of depression are related to altered autonomic function. We expect that postmenopausal women with depressive symptoms who receive breathing training will demonstrate decreased depressive symptoms and increased heart rate variability immediately upon and later after completion of training, and optimally contributing to improve autonomic nervous regulation in their later life to prevent undesired cardiac outcomes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Respiratory sinus arrhythmia biofeedback-assisted deep breathing training
Cognitive reconstructive strategies for stress management
Taipei Medical University Hospital
Taipei, Xinyi Dist., Taiwan
Depressive symptoms
Time frame: baseline
Depressive symptoms
Time frame: posttest (8 weeks from baseline)
Depressive symptoms
Time frame: follow-up (16 weeks from baseline)
Heart rate variability (Resting, reactivity to stress, and recovery from stress)
Time frame: baseline
Heart rate variability (Resting, reactivity to stress, and recovery from stress)
Time frame: posttest (8 weeks from baseline)
Heart rate variability (Resting, reactivity to stress, and recovery from stress)
Time frame: follow-up (16 weeks from baseline)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.